X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs PFIZER - Comparison Results

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB PFIZER UNICHEM LAB/
PFIZER
 
P/E (TTM) x -32.9 34.0 - View Chart
P/BV x 0.7 4.8 14.8% View Chart
Dividend Yield % 2.4 0.7 334.2%  

Financials

 UNICHEM LAB   PFIZER
EQUITY SHARE DATA
    UNICHEM LAB
Mar-18
PFIZER
Mar-18
UNICHEM LAB/
PFIZER
5-Yr Chart
Click to enlarge
High Rs3822,365 16.2%   
Low Rs2341,625 14.4%   
Sales per share (Unadj.) Rs116.3430.3 27.0%  
Earnings per share (Unadj.) Rs-18.978.7 -24.0%  
Cash flow per share (Unadj.) Rs-11.793.2 -12.6%  
Dividends per share (Unadj.) Rs5.0020.00 25.0%  
Dividend yield (eoy) %1.61.0 161.9%  
Book value per share (Unadj.) Rs381.0586.5 65.0%  
Shares outstanding (eoy) m70.3445.75 153.7%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.64.6 57.1%   
Avg P/E ratio x-16.325.3 -64.2%  
P/CF ratio (eoy) x-26.221.4 -122.6%  
Price / Book Value ratio x0.83.4 23.8%  
Dividend payout %-26.425.4 -104.0%   
Avg Mkt Cap Rs m21,66891,271 23.7%   
No. of employees `0002.32.6 86.7%   
Total wages/salary Rs m2,0063,143 63.8%   
Avg. sales/employee Rs Th3,587.87,484.8 47.9%   
Avg. wages/employee Rs Th880.01,195.0 73.6%   
Avg. net profit/employee Rs Th-583.71,369.1 -42.6%   
INCOME DATA
Net Sales Rs m8,18019,685 41.6%  
Other income Rs m6101,143 53.4%   
Total revenues Rs m8,79020,828 42.2%   
Gross profit Rs m-1,3205,003 -26.4%  
Depreciation Rs m505663 76.2%   
Interest Rs m804 1,907.1%   
Profit before tax Rs m-1,2955,479 -23.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m331,878 1.8%   
Profit after tax Rs m-1,3313,601 -37.0%  
Gross profit margin %-16.125.4 -63.5%  
Effective tax rate %-2.634.3 -7.5%   
Net profit margin %-16.318.3 -88.9%  
BALANCE SHEET DATA
Current assets Rs m23,31824,167 96.5%   
Current liabilities Rs m4,6359,544 48.6%   
Net working cap to sales %228.474.3 307.5%  
Current ratio x5.02.5 198.7%  
Inventory Days Days12255 221.0%  
Debtors Days Days12129 423.2%  
Net fixed assets Rs m8,1639,514 85.8%   
Share capital Rs m141458 30.8%   
"Free" reserves Rs m26,66026,375 101.1%   
Net worth Rs m26,80126,832 99.9%   
Long term debt Rs m325 13.2%   
Total assets Rs m31,89036,900 86.4%  
Interest coverage x-15.21,305.5 -1.2%   
Debt to equity ratio x00 13.2%  
Sales to assets ratio x0.30.5 48.1%   
Return on assets %-3.99.8 -40.1%  
Return on equity %-5.013.4 -37.0%  
Return on capital %-4.520.4 -22.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m4,35622 19,448.2%   
Fx outflow Rs m01,489 0.0%   
Net fx Rs m4,356-1,466 -297.1%   
CASH FLOW
From Operations Rs m-1,1233,318 -33.9%  
From Investments Rs m16,487-2,383 -691.8%  
From Financial Activity Rs m-8,811-1,104 798.5%  
Net Cashflow Rs m6,552-169 -3,888.4%  

Share Holding

Indian Promoters % 50.1 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 15.1 7.5 201.3%  
FIIs % 3.0 4.9 61.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 23.7 133.8%  
Shareholders   20,176 85,207 23.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   AJANTA PHARMA  GLENMARK PHARMA  SUN PHARMA  STRIDES PHARMA SCIENCE  FDC LTD.  

Compare UNICHEM LAB With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 300 Points Lower; Metal and IT Stocks Witness Selling(Closing)

Share markets in India witnessed most of the selling pressure during closing hours and ended their trading session on a negative note.

Related Views on News

PFIZER Announces Quarterly Results (2QFY19); Net Profit Down 13.8% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, PFIZER has posted a net profit of Rs 958 m (down 13.8% YoY). Sales on the other hand came in at Rs 5 bn (down 9.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

5G Stocks: Cutting-Edge Technology that Could Make You Very Rich...(Profit Hunter)

Nov 12, 2018

A brand new technology and a stock that could soar with the upcoming 5G rollout.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Investing In Small Cap Funds? Read This Before You Invest(Outside View)

Nov 19, 2018

PersonalFN explains the care to take when investing in small-cap funds and the approach to follow.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Nov 20, 2018 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS